Ivakam 5 Tablet contains Ivabradine 5 mg, a selective sinus node inhibitor used primarily for the management of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, leading to a reduction in heart rate without affecting myocardial contractility or intracardiac conduction. This mechanism helps decrease myocardial oxygen demand, thereby alleviating angina symptoms and improving exercise tolerance in patients with coronary artery disease. Ivakam 5 is indicated for patients with stable angina who are intolerant to or inadequately controlled by beta-blockers, as well as for patients with chronic heart failure with reduced ejection fraction who remain symptomatic despite optimal standard therapy. The usual dosage is one tablet twice daily, adjusted according to heart rate and clinical response, with careful monitoring to avoid bradycardia. Ivabradine should be used cautiously in patients with conduction abnormalities, atrial fibrillation, or severe hepatic impairment. Common adverse effects include bradycardia, luminous phenomena (phosphenes), and headache. Ivakam 5 Tablet should be prescribed and administered under medical supervision, with regular assessment of heart rate and rhythm to ensure safety and efficacy.